The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
Fernández
M A
MA
Andreu
R
R
Fortea
J M
JM
Aznar
J
J
D000074:Acenocoumarol / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D001014:Aortic Aneurysm / Q000150:complications; D002545:Brain Ischemia / Q000150:complications / Q000517:prevention & control; D003490:Cyanosis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology*; D013927:Thrombosis / Q000150:complications; D014034:Toes / Q000098:blood supply*; D001749:Urinary Bladder Neoplasms / Q000150:complications
D000925:Anticoagulants; D006493:Heparin; D000074:Acenocoumarol